Founded in 1996 and headquartered in Basel, Switzerland, Novartis is a global innovative medicines company dedicated to reimagining medicine to improve and extend people's lives. With a workforce of approximately 109,000 people worldwide, the company operates at significant scale, reaching over 280 million patients globally with its treatments. Its therapeutic focus spans oncology, immunology, cardiovascular diseases, and renal and metabolic diseases - areas where medical advances can have outsized impact on human health.
Novartis maintains deep expertise across drug development, treatment options, advanced technology, data platforms, research and operations, and enterprise data management. This breadth of technical capability supports a research-driven approach to identifying and delivering patient-centered solutions. The company's commitment to innovation is embedded in its operational model, which integrates scientific research with large-scale data infrastructure to accelerate the path from discovery to treatment.
The organisation values collaboration and community alongside its pursuit of scientific and operational excellence. For professionals in the pharmaceutical and healthcare sectors, Novartis presents an environment where rigorous work in areas such as oncology, immunology, and cardiovascular research directly translates into treatments reaching hundreds of millions of people - a scale of impact that few organisations in the industry can match.
